• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Model Number 1550225-28
Device Problems Improper or Incorrect Procedure or Method (2017); Failure to Advance (2524)
Patient Problem Perforation (2001)
Event Date 12/28/2020
Event Type  Injury  
Manufacturer Narrative
(b)(4).The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.Additionally, a review of the complaint history did not indicate a lot specific quality issue.It should be noted that the xience sierra, everolimus eluting coronary stent system (eecss), electronic instructions for use states: an unexpanded stent may be retracted into the guiding catheter one time only.An unexpanded stent should not be reintroduced into the artery once it has been pulled back into the guiding catheter.Subsequent movement in and out through the distal end of the guiding catheter should not be performed, as the stent may be damaged or dislodge during retraction back into the guiding catheter.The reported patient effect of perforation is listed in the xience sierra, everolimus eluting coronary stent system (eecss), electronic instructions for use as a known patient effect of coronary stenting procedures.The investigation determined the reported failure to advance and subsequent treatment appear to be related to the operational context of the procedure.A conclusive cause for the reported patient effect, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to the design, manufacture or labeling of the device.
 
Event Description
It was reported that the procedure was performed to treat a mildly calcified, mildly tortuous, de novo mid ramus that was 100% stenosed.Pre-dilatation was done with a 1.2x12mm trek balloon, a 2x15mm trek balloon, and a 2.5x15mm trek balloon.The 2.25x28mm xience sierra stent delivery system (sds) was advanced using a guiding catheter but failed to cross due to the anatomy.Using a new guide support catheter, a second attempt was made to cross but failed again due to the anatomy.A perforation was then observed.Additional dilatation was done and the sds was reattempted but did not cross.The xience sierra sds was replaced with a 2.25x26mm non-abbott sds.The replacement device crossed immediately and was deployed.Post-dilatation was done with long inflations to successfully treat the perforation.There was no adverse patient sequela reported.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key11156581
MDR Text Key226326245
Report Number2024168-2021-00351
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08717648227042
UDI-Public08717648227042
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 01/12/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/26/2021
Device Model Number1550225-28
Device Catalogue Number1550225-28
Device Lot Number0052141
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/29/2020
Initial Date FDA Received01/12/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
GUIDEZILLA GUIDELINER
Patient Outcome(s) Required Intervention;
Patient Age80 YR
Patient Weight88
-
-